Harvest Investment Services, LLC Incyte Corp Transaction History

Harvest Investment Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$68.67 - $84.02 $187,606 - $229,542	-2,732 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$79.87 - $87.53 $18,370 - $20,131	-230 Reduced 7.77%	2,732 $229,000
Q1 2021 May 06, 2021	SELL	$76.02 - $100.5 $1,976 - $2,613	-26 Reduced 0.87%	2,962 $240,000
Q4 2020 Feb 01, 2021	BUY	$80.74 - $97.7 $10,980 - $13,287	136 Added 4.77%	2,988 $259,000
Q3 2020 Oct 29, 2020	SELL	$85.07 - $109.69 $19,225 - $24,789	-226 Reduced 7.34%	2,852 $255,000
Q2 2020 Aug 11, 2020	BUY	$74.18 - $108.93 $228,326 - $335,286	3,078 New	3,078 $320,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.